59.18
price up icon27.71%   12.84
pre-market  プレマーケット:  60.50   1.32   +2.23%
loading
前日終値:
$46.34
開ける:
$47.53
24時間の取引高:
42.61M
Relative Volume:
2.72
時価総額:
$12.93B
収益:
$1.24B
当期純損益:
$101.26M
株価収益率:
134.50
EPS:
0.44
ネットキャッシュフロー:
$149.62M
1週間 パフォーマンス:
+46.23%
1か月 パフォーマンス:
+128.49%
6か月 パフォーマンス:
+270.34%
1年 パフォーマンス:
+524.26%
1日の値動き範囲:
Value
$47.14
$59.55
1週間の範囲:
Value
$41.30
$59.55
52週間の値動き範囲:
Value
$9.222
$59.55

Hims Hers Health Inc Stock (HIMS) Company Profile

Name
名前
Hims Hers Health Inc
Name
電話
415-851-0195
Name
住所
2269 CHESTNUT ST, SAN FRANCISCO
Name
職員
1,046
Name
Twitter
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
HIMS's Discussions on Twitter

HIMS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Household & Personal Products icon
HIMS
Hims Hers Health Inc
59.18 12.93B 1.24B 101.26M 149.62M 0.44
Household & Personal Products icon
PG
Procter Gamble Co
171.02 401.02B 84.35B 15.48B 15.47B 6.28
Household & Personal Products icon
UL
Unilever Plc Adr
55.96 138.40B 64.93B 7.15B 0 2.832
Household & Personal Products icon
CL
Colgate Palmolive Co
87.75 71.69B 20.10B 2.89B 3.55B 3.52
Household & Personal Products icon
KMB
Kimberly Clark Corp
135.36 44.91B 20.06B 2.55B 2.51B 7.55
Household & Personal Products icon
KVUE
Kenvue Inc
21.45 41.13B 15.46B 1.03B 1.40B 0.53

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 ダウングレード Citigroup Neutral → Sell
2025-01-07 開始されました BTIG Research Buy
2024-12-17 開始されました Morgan Stanley Overweight
2024-11-14 ダウングレード BofA Securities Buy → Underperform
2024-08-22 開始されました Needham Buy
2024-08-09 ダウングレード Imperial Capital Outperform → In-line
2024-05-22 ダウングレード Citigroup Buy → Neutral
2024-04-16 ダウングレード Jefferies Buy → Hold
2024-04-10 開始されました Canaccord Genuity Buy
2024-02-28 アップグレード Imperial Capital In-line → Outperform
2024-02-26 開始されました Leerink Partners Market Perform
2023-12-07 開始されました Imperial Capital In-line
2023-07-28 開始されました TD Cowen Outperform
2023-04-11 開始されました Robert W. Baird Neutral
2023-02-09 アップグレード Jefferies Hold → Buy
2022-11-08 アップグレード BofA Securities Neutral → Buy
2022-11-08 アップグレード SVB Leerink Mkt Perform → Outperform
2022-10-17 ダウングレード Piper Sandler Overweight → Neutral
2022-09-07 開始されました Truist Hold
2022-07-15 開始されました SVB Leerink Underperform
2022-04-14 開始されました Guggenheim Buy
2022-04-01 再開されました Credit Suisse Outperform
2022-03-10 開始されました Deutsche Bank Hold
2021-12-02 開始されました Jefferies Hold
2021-11-11 アップグレード Piper Sandler Neutral → Overweight
2021-07-06 開始されました BofA Securities Neutral
2021-05-20 アップグレード Credit Suisse Neutral → Outperform
2021-04-21 開始されました Truist Hold
2021-03-09 開始されました Credit Suisse Neutral
2021-03-02 アップグレード Citigroup Neutral → Buy
2021-02-17 開始されました Citigroup Neutral
2021-02-12 開始されました Piper Sandler Neutral
2021-02-08 開始されました Tigress Financial Buy
すべてを表示

Hims Hers Health Inc (HIMS) 最新ニュース

pulisher
06:39 AM

Hims & Hers markets itself in a very 2025 way: by picking a fight - Fast Company

06:39 AM
pulisher
02:55 AM

Hims & Hers Health (HIMS) Surges 27.7%: Is This an Indication of Further Gains? - Yahoo Finance

02:55 AM
pulisher
02:03 AM

Why Hims & Hers Health Inc. (HIMS) Went Up on Thursday - MSN

02:03 AM
pulisher
Feb 13, 2025

Hims & Hers jumps after RFK Jr. confirmation - Sherwood News

Feb 13, 2025
pulisher
Feb 13, 2025

Hims & Hers Stock Soars on Momentum From Super Bowl Ad, RFK Confirmation - The Wall Street Journal

Feb 13, 2025
pulisher
Feb 13, 2025

Hims & Hers Health (NYSE:HIMS) Reaches New 1-Year HighStill a Buy? - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Hims & Hers stock sees another spike in trading days after Super Bowl ad - Yahoo Finance

Feb 13, 2025
pulisher
Feb 13, 2025

Medical Stocks To ConsiderFebruary 13th - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

HIMS Stock Hits New ATH After Successful Super Bowl Ad - Markets Insider

Feb 13, 2025
pulisher
Feb 13, 2025

Hims & Hers Health Faces Insider Trading Amid Stock Fluctuations - Evrim Ağacı

Feb 13, 2025
pulisher
Feb 13, 2025

3 Weight-Loss Drug Stocks to Watch - Schaeffers Research

Feb 13, 2025
pulisher
Feb 13, 2025

Why Novo Nordisk Stock Keeps Going Down - The Motley Fool

Feb 13, 2025
pulisher
Feb 13, 2025

Hims & Hers health chief commercial officer sells $314k in stock - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Hims & Hers sees 650% spike in traffic following Super Bowl ad as clash over compounded GLP-1s heats up - Fierce healthcare

Feb 13, 2025
pulisher
Feb 13, 2025

Hims & Hers Health (NYSE:HIMS) Stock Quotes, Forecast and News Summary - Benzinga

Feb 13, 2025
pulisher
Feb 12, 2025

Hims & Hers stock price target according to the C&H pattern - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 7,259 Shares of Stock - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells 11,581 Shares of Stock - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Hims Hers Health stock adds to gains amid Super Bowl ad impact - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

HIMS stock soars to all-time high, reaching $46.11 - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials - Starved Rock Media

Feb 12, 2025
pulisher
Feb 12, 2025

'We cannot stay silent': Novo Nordisk flags dangers of compounded GLP-1s following Hims & Hers Super Bowl ad - FiercePharma

Feb 12, 2025
pulisher
Feb 12, 2025

Why Hims & Hers Terrifies Big Pharma - Barchart

Feb 12, 2025
pulisher
Feb 12, 2025

Hims & Hers Super Bowl ad sparks weight-loss drug backlash - NewsNation Now

Feb 12, 2025
pulisher
Feb 12, 2025

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Hims & Hers Option Trade Offers $410 Return Or 17% Discount - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Yousif Capital Management LLC Takes $1.79 Million Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Hims & Hers: Firing On All Cylinders, But Expensive - Seeking Alpha

Feb 12, 2025
pulisher
Feb 11, 2025

Super Bowl ad for Hims & Hers' weight loss drug sparks backlash - ABC News

Feb 11, 2025
pulisher
Feb 11, 2025

Super Bowl ad for weight loss drug sparks backlash - Good Morning America

Feb 11, 2025
pulisher
Feb 11, 2025

Hims & Hers Health Executives Sell Shares Under Trading Plans - TradingView

Feb 11, 2025
pulisher
Feb 11, 2025

Hims and Hers under scrutiny after weight loss ad during Super Bowl - WHAS11.com

Feb 11, 2025
pulisher
Feb 11, 2025

‘Check before you inject’: Novo bites back at Hims & Hers Super Bowl ad - MM+M Online

Feb 11, 2025
pulisher
Feb 11, 2025

Hims Stock: The Future of Telehealth Investment? - Reporteros del Sur

Feb 11, 2025
pulisher
Feb 11, 2025

Hims & Hers Health Stock Gains 77% YTD as Earnings Approaching - AskTraders

Feb 11, 2025
pulisher
Feb 11, 2025

Hims & Hers' Super Bowl ad sparks backlash - Good Morning America

Feb 11, 2025
pulisher
Feb 11, 2025

Charly AI rated this stock a BUY, 3 months ago. Now it is up 116% - substack.com

Feb 11, 2025
pulisher
Feb 11, 2025

Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

State of Alaska Department of Revenue Invests $2.63 Million in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Hims & Hers Takes Aim At Big Pharma In Controversial Super Bowl Ad — Retail Loves The Fight - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Hims & Hers Health: Explosive Growth Potential Ahead - Seeking Alpha

Feb 11, 2025
pulisher
Feb 10, 2025

Hims & Hers Health (NYSE:HIMS) Sets New 52-Week HighStill a Buy? - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs - Livescience.com

Feb 10, 2025
pulisher
Feb 10, 2025

Monday Morning (Advertising) Quarterback – Unprecedented Hims & Hers Super Bowl Ad Has Legislators Concerned - The National Law Review

Feb 10, 2025
pulisher
Feb 10, 2025

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

Hims & Hers Stock Bounces After Super Bowl Ad - The Wall Street Journal

Feb 10, 2025
pulisher
Feb 10, 2025

Ozempic, Wegovy maker responds to Hims & Hers Super Bowl ad - Modern Healthcare

Feb 10, 2025
pulisher
Feb 10, 2025

On Super Bowl Sunday, ads for junk food and dessert bump up against weight-loss drugs - Marketing Brew

Feb 10, 2025
pulisher
Feb 10, 2025

Hims & Hers Health Unusual Options Activity For February 10 - Benzinga

Feb 10, 2025
pulisher
Feb 10, 2025

Now BIO bashes Hims & Hers as obesity ad aires - The Pharma Letter

Feb 10, 2025

Hims Hers Health Inc (HIMS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
household_personal_products CLX
$150.77
price up icon 1.43%
$5.75
price up icon 1.23%
household_personal_products CHD
$107.53
price up icon 1.49%
household_personal_products EL
$69.67
price up icon 0.93%
$21.45
price up icon 2.34%
大文字化:     |  ボリューム (24 時間):